Known For
Recent Appearances
✨
Finding effective comparators for psilocybin trials is challenging.
✨
Dr. Woolley defends UMBRAA, a blinding framework for psilocybin trials.
✨
UMBRAA framework proposed to fix psilocybin trial blinding.
✨
Masking in high-dose psilocybin trials is ineffective, with >90% participant awareness.